ASX:OCCPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Orthocell Ltd
$0.715
$0.005 (0.69%)
Day Range
$0.710 – $0.720
52 Week Range
$0.700 – $1.600
Volume
186.50K
Avg Volume (10D)
420.64K
Market Cap
$194.72M
Price Chart
Market Statistics
Open$0.720
Previous Close$0.720
Day High$0.720
Day Low$0.710
52 Week High$1.600
52 Week Low$0.700
Valuation
Market Cap194.72M
Shares Outstanding272.33M
Price to Book4.75
Trading Activity
Volume186.50K
Value Traded133.01K
Bid$0.710 × 30,000
Ask$0.720 × 12,777
Performance
1 Day0.70%
5 Day-5.26%
13 Week-20.00%
52 Week-48.01%
YTD-33.64%
Technical Indicators
RSI (14)39.65
50-Day SMA$0.773
200-Day SMA$0.939
Latest News
Biotechnology
Orthocell Appoints MediTime as Thai Distributor for Remplir Nerve Repair
Orthocell names MediTime exclusive Thai distributor for Remplir nerve repair, taps US$84m market; Thai FDA CY25 approval; $48m cash, no debt.
Biotechnology
Orthocell Secures Access to 221 US Military & VA Medical Centres for Remplir
Orthocell wins access to 221 US DoD/VA centres for Remplir, a major US market expansion as HY26 revenue hits A$6.2m and cash sits at A$49.4m.
Biotechnology
Orthocell's Remplir Device Used in 23 Ukrainian Soldier Surgeries, Validating Field Utility
Orthocell's Remplir validated after 23 Ukrainian surgeries, boosting defence-market traction and global expansion; HY26 revenue +49%, cash ~A$49m.
Biotechnology
Orthocell Appoints Exclusive Remplir Distributor Ahead of UK Rollout
Orthocell names LEDA Orthopaedics exclusive UK distributor for Remplir ahead of regulatory approval, signaling rapid UK rollout and market prep.